Přihlásit se Zaregistrujte se zdarma

1letý cíl společnosti IMV

Jaká je hodnota metriky 1letý cíl společnosti IMV?

Hodnota metriky 1letý cíl společnosti IMV, Inc. je CAD$41 +3,523.91%

Jaká je definice metriky 1letý cíl?

1-letý cíl (1-year target) je analytiky předpokládaná cena akcie za rok od dnešního dne.

One year target is an estimate of a stock price for a point in time equal to a year from the current date. The price level most often reflects the collective opinion of different analysts on where the stock will be trading a year from now. For an analyst to identify an individual estimate, they have to project what a company’s business will look like in a year, typically focusing on revenue and other significant factors. They also consider the willingness of investors to pay a certain price. While the average or median recommendation may be predictive and reflect the actual future value, the results are usually not extremely successful.

1letý cíl společností v sektoru Health Care sektor na TSX ve srovnání se společností IMV

Čemu se věnuje společnost IMV?

IMV Inc. operates as a clinical-stage immuno-oncology company. The company develops a portfolio of therapies based on DPX its immune-educating technology platform for treatment of solid and hematological cancers. The company's lead drug candidate includes maveropepimut-S, a DPX-based immunotherapy that targets survivin-expressing cells that is Phase II clinical trials for diffuse large B cell lymphoma; ovarian cancer; and bladder, liver, and microsatellite instability high tumors, as well as in Phase I clinical trial for breast cancer. It also develops DPX-SurMAGE that is in Phase I clinical trial for bladder cancer; and DPX-COVID-19 and DPX-RSV for infectious diseases. The company was formerly known as Immunovaccine Inc. and changed its name to IMV Inc. in May 2018. IMV Inc. was founded in 2000 and is headquartered in Dartmouth, Canada.

Firmy s metrikou 1letý cíl podobnou společnosti IMV